Incannex Healthcare Files 8-K: Board & Compensation Updates
Ticker: IXHL · Form: 8-K · Filed: Mar 5, 2024 · CIK: 1873875
| Field | Detail |
|---|---|
| Company | Incannex Healthcare Inc. (IXHL) |
| Form Type | 8-K |
| Filed Date | Mar 5, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $205,000, $200,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, filing-update
TL;DR
Incannex Healthcare filed an 8-K on Feb 29, 2024, detailing board changes and compensation. Check for leadership impact.
AI Summary
Incannex Healthcare Inc. filed an 8-K on February 29, 2024, reporting changes in its board of directors and executive compensation arrangements. The filing also includes financial statements and exhibits, with the earliest event reported being February 29, 2024. The company is incorporated in Delaware and its fiscal year ends on June 30.
Why It Matters
This filing provides insight into potential shifts in company leadership and executive pay structures, which can impact strategic direction and investor confidence.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding board and compensation matters, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- Incannex Healthcare Inc. (company) — Registrant
- February 29, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- June 30 (date) — Fiscal Year End
FAQ
What specific changes were made to the board of directors?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers', but the specific names and details of these changes are not provided in the provided text excerpt.
What are the details of the compensatory arrangements for certain officers?
The filing mentions 'Compensatory Arrangements of Certain Officers' as an item of disclosure, but the specific details of these arrangements are not included in the provided text excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on February 29, 2024.
In which state is Incannex Healthcare Inc. incorporated?
Incannex Healthcare Inc. is incorporated in Delaware.
What is the company's fiscal year end?
The company's fiscal year end is June 30.
Filing Stats: 788 words · 3 min read · ~3 pages · Grade level 12 · Accepted 2024-03-05 06:11:11
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IXHL The Nasdaq
- $205,000 — will receive an annual base salary of A$205,000. Mr. Swan will also be eligible to rece
- $200,000 — ets are met and up to a total value of A$200,000 of shares of common stock of the Compan
Filing Documents
- ea0201207-8k_incannex.htm (8-K) — 29KB
- ea0201207ex10-1_incannex.htm (EX-10.1) — 166KB
- ex10-1_001.jpg (GRAPHIC) — 3KB
- 0001213900-24-019724.txt ( ) — 389KB
- ixhl-20240229.xsd (EX-101.SCH) — 3KB
- ixhl-20240229_lab.xml (EX-101.LAB) — 33KB
- ixhl-20240229_pre.xml (EX-101.PRE) — 22KB
- ea0201207-8k_incannex_htm.xml (XML) — 4KB
02 Departure
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Madhukar Bhalla, Chief Financial Officer and Secretary of Incannex Healthcare Inc. (the "Company"), recently notified the Company of his decision to resign from his positions effective as of February 28, 2024. Mr. Bhalla's decision does not reflect any disagreement with, or the existence of any irregularities in, the Company's operations, policies, accounting principles, practices, financial statements or disclosures. The Company's Board of Directors has appointed Joseph Swan, the current Treasurer and Controller of the Company, as its Chief Financial Officer and Secretary effective as of February 29, 2024. Mr. Swan will maintain his position as Treasurer of the Company. Mr. Swan, age 32, has been the Treasurer and Controller of the Company since July 2023 and he was Head of Finance of Incannex Healthcare Limited ("Incannex Australia") from November 2021 to November 2023, when Incannex Australian re-domicilied to Delaware with the Company becoming the parent entity and Incannex Australia becoming a subsidiary. Prior to joining Incannex Australia, Mr. Swan had been an Audit Supervisor at HLB Mann Judd, an Australian accounting and advisory firm, from May 2020 to November 2021, an internal auditor an INPEX Australia, an energy company, from July 2017 to July 2018 and an analyst at Deloitte Australia from February 2015 to June 2017. Mr. Swan is a chartered accountant in Australia and New Zealand and holds a university degree in commerce and accounting from the University of Western Australia. During his career, Mr. Swan has been responsible for reviewing financial statements and preparing audit report, both as independent auditor and in-house accountant. In particular, Mr. Swan has been tasked with coordinating the audit team dedicated to the preparation and delivery of financial statements and audit reports.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Employment Agreement, dated February 27, 2024, between Incannex Healthcare Inc. and Joseph Swan 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Incannex Healthcare Inc. Date: March 5, 2024 /s/ Joel Latham Name: Joel Latham Title: Chief Executive Officer and President 2